Are trial participants adequately safeguarded by the ethics committees—the Indian scenario?

por Thakkar, Karan, Billa, Gauri
Publicado 2014

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs

por Thakkar, Karan B., Billa, Gauri
Publicado 2013

Light at the end of the tunnel?: The Great Indian Pharmacoeconomics story

por Thakkar, Karan B., Billa, Gauri
Publicado 2013

Practice of Pain Management by Indian Healthcare Practitioners: Results of a Paper Based Questionnaire Survey

por Billa, Gauri, Gabhane, Mukesh, Biswas, Swati
Publicado 2015

A study to assess completeness of project application forms submitted to Institutional Ethics Committees (IEC) of a tertiary care hospital

por Shetty, Yashashri C., Marathe, Padmaja A., Billa, Gauri V., Nambiar, C. P. Neelima
Publicado 2012

Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study

por Jain, Anil Ranjeetmal, Aggarwal, Rakesh Kumar, Rao, Nanyam Srinivas, Billa, Gauri, Kumar, Shankar
Publicado 2020

Durapain in symptomatic treatment of severe acute pain: a post-marketing, prospective, multicenter, observational study – PRIME study

por Shah, Kshitij, Chaudhari, Omvijay B, Gupta, Palash, Chaudhuri, R Hom, Kamilya, Ranjan, Kulkarni, Shreedhar S, Subbaiah, S, Sorathia, Zubair H, Billa, Gauri
Publicado 2017